|
OXNAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.54930000004516E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.355690E-04 |
| Normal-vs-Stage2 |
1.188960E-01 |
| Normal-vs-Stage3 |
1.31770000022513E-07 |
| Normal-vs-Stage4 |
7.0216999992212E-08 |
| Stage1-vs-Stage2 |
6.264200E-02 |
| Stage1-vs-Stage3 |
2.672300E-02 |
| Stage1-vs-Stage4 |
1.732140E-02 |
| Stage2-vs-Stage3 |
1.139940E-03 |
| Stage2-vs-Stage4 |
4.619900E-04 |
| Stage3-vs-Stage4 |
5.077800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19249999985804E-07 |
| Normal-vs-AfricanAmerican |
2.101600E-03 |
| Normal-vs-Asian |
5.67750000000089E-05 |
| Caucasian-vs-AfricanAmerican |
7.727400E-01 |
| Caucasian-vs-Asian |
8.944000E-01 |
| AfricanAmerican-vs-Asian |
7.359000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.621020E-03 |
| Normal-vs-Female |
2.2201000005051E-07 |
| Male-vs-Female |
1.120220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.227600E-04 |
| Normal-vs-Age(41-60Yrs) |
6.16590000168671E-08 |
| Normal-vs-Age(61-80Yrs) |
1.444140E-03 |
| Normal-vs-Age(81-100Yrs) |
1.841150E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.217700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.378200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.514000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.183500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.855610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.950200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.761800E-02 |
| Classical-VS-Follicular |
4.26610000000549E-05 |
| Classical-VS-Other |
9.476200E-01 |
| Classical-VS-Normal |
7.02510000172296E-08 |
| Tall-VS-Follicular |
3.421500E-04 |
| Tall-VS-Other |
4.944600E-01 |
| Tall-VS-Normal |
2.00930000004984E-06 |
| Follicular-VS-Other |
1.784550E-01 |
| Follicular-VS-Normal |
4.039400E-01 |
| Other-VS-Normal |
3.197700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.761690E-04 |
| Normal-vs-N1 |
6.94270000378694E-08 |
| N0-vs-N1 |
1.987650E-02 |
|
|
